Pseudoathetosis in a patient with leprosy.
A 35-year-old man with borderline tuberculoid leprosy developed Type I lepra reaction 12 days after anti-leprosy treatment. There was acute worsening of neuropathic symptoms and skin lesions. He developed severe sensory ataxia and pseudoathetosis resulting in marked disability. His symptoms significantly improved on corticosteroid therapy.
Misra
Usha Kant
UK
Department of Neurology, Sanjay Gandhi PGIMS, Lucknow, India. ukmisra@sgpgi.ac.in
Kalita
Jayantee
J
Mahadevan
Anita
A
Shankar
Susarla Krishna
SK
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001264:Athetosis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D001706:Biopsy; D003937:Diagnosis, Differential; D005073:Evoked Potentials, Somatosensory / Q000502:physiology; D006801:Humans; D006818:Hyalin / Q000378:metabolism; D015441:Leprosy, Tuberculoid / Q000150:complications* / Q000175:diagnosis*; D008297:Male; D018482:Muscle, Skeletal / Q000503:physiopathology; D009431:Neural Conduction / Q000502:physiology; D011239:Prednisolone / Q000627:therapeutic use; D012678:Sensation Disorders / Q000209:etiology; D012720:Severity of Illness Index; D013497:Sural Nerve / Q000378:metabolism / Q000473:pathology
D000893:Anti-Inflammatory Agents; D011239:Prednisolone